يعرض 61 - 80 نتائج من 65,964 نتيجة بحث عن '(( 5 ((a decrease) OR (mean decrease)) ) OR ((( 5 nm decrease ) OR ( 5 we decrease ))))', وقت الاستعلام: 1.10s تنقيح النتائج
  1. 61

    Fig 5 Data. حسب Kevin D. Gaitonde (15411707)

    منشور في 2023
    الموضوعات:
  2. 62

    Mean decrease in accuracy (MDA) of top 15 urine metabolites. حسب Liam E. Broughton-Neiswanger (8447220)

    منشور في 2020
    "…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…"
  3. 63
  4. 64

    Image_5_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif حسب Wan Fu (3681799)

    منشور في 2021
    "…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …"
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79

    Structure-Based Design of a Chemical Probe Set for the 5‑HT<sub>5A</sub> Serotonin Receptor حسب Anat Levit Kaplan (12126567)

    منشور في 2022
    "…Docking over 6 million molecules against a 5-HT<sub>5A</sub>R homology model identified 5 mid-μM ligands, one of which was optimized to <b>UCSF678</b>, a 42 nM arrestin-biased partial agonist at the 5-HT<sub>5A</sub>R with a more restricted off-target profile and decreased assay liabilities versus SB-699551. …"
  20. 80

    Structure-Based Design of a Chemical Probe Set for the 5‑HT<sub>5A</sub> Serotonin Receptor حسب Anat Levit Kaplan (12126567)

    منشور في 2022
    "…Docking over 6 million molecules against a 5-HT<sub>5A</sub>R homology model identified 5 mid-μM ligands, one of which was optimized to <b>UCSF678</b>, a 42 nM arrestin-biased partial agonist at the 5-HT<sub>5A</sub>R with a more restricted off-target profile and decreased assay liabilities versus SB-699551. …"